Labcorp will host a fireside chat at the J.P. Morgan Healthcare Conference. Get details on the Labcorp investor conference, ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Labcorp Holdings recently reported better-than-expected Q3 2025 adjusted EPS of $4.18 but cut its contract research unit’s annual and full-year revenue growth forecasts due to a prolonged funding ...

Labcorp Holdings ( (LH)) has provided an update. On December 10, 2025, Labcorp Holdings announced the retirement of Dr. D. Gary Gilliland from its Board of Directors, effective December 31, 2025. Dr.

Transaction aims to provide broader access to high-quality testing and laboratory services to communities across the U.S. Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today ...

Management cited the divestiture and consolidation of non-core early development sites, resulting in a reduction of approximately $50 million in annual revenue. The company lowered its midpoint ...

Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18. Sales increased 8.6% year-over-year to ...

Labcorp Holdings Inc (NYSE:LH) released its third quarter 2025 financial results on October 28, showing solid growth across all business segments despite broader market volatility. The diagnostic ...

Labcorp Holdings reported robust financial results for the third quarter of 2025, with adjusted earnings per share (EPS) surpassing expectations and revenue meeting forecasts. The company recorded an ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...